FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of…

Misuse of Adderall promotes stigma and mistrust for patients who need it – a neuroscientist explains the science behind the controversial ADHD drug

The nationwide shortages of Adderall that began in fall 2022 have brought renewed attention to the beleaguered drug, which is used to treat attention-deficit/hyperactivity disorder and narcolepsy. Adderall became a…